The expanding role of topical tacrolimus in dermatology

Clinical and Experimental Dermatology

Volumn 30, Issue 2, 2005, Pages 111-115

  Evans, A V ^a  

^a PRINCESS OF WALES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; ORABASE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

CHEILITIS; DERMATOMYOSITIS; DRUG INDICATION; FOLLICULITIS; GRANULOMA; HUMAN; LICHEN PLANUS; PRIORITY JOURNAL; PUSTULAR PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; ROSACEA; SCLERODERMA; VITILIGO;

ADMINISTRATION, CUTANEOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SKIN DISEASES; TACROLIMUS;

EID: 15044353102     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01730.x     Document Type: Review

References (46)

1. Zonneveld IM, Rubins A, Jablonska S et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998; 134: 1101-2.
2. Mrowietz U, Graeber M, Brautigam M et al. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. Br J Dermatol 1998; 139: 992-6.
3. Freeman AK, Linowski GJ, Brady C et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003; 48: 564-8.
4. Nagao K, Ishiko A, Yokoyama T et al. A case of generalized pustular psoriasis treated with topical tacrolimus. Arch Dermatol 2003; 139: 1219.
5. Jensen JT, Bird M, Leclair CM. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study. Am J Obstet Gynecol 2004; 190: 1759-63.
6. Hodgson TA, Sahni N, Kaliakatsou F et al. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol 2003; 13: 466-70.
7. Olivier V, Lacour JP, Mousnier A et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol 2002; 138: 1335-8.
8. Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis 2003; 71: 158-62.
9. Lepe V, Moncada B, Castanedo-Cazares JP et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003; 139: 581-5.
10. Connolly M, Kennedy C. Exfoliative cheilitis successfully treated with topical tacrolimus. Br J Dermatol 2004; 151: 241-2.
11. Rubegni P, Sbano P, Risulo M et al. A case of reticular erythematous mucinosis treated with topical tacrolimus. Br J Dermatol 2004; 150: 173-4.
12. Mallipeddi R, Evans AV. Refractory pityriasis lichenoides chronica successfully treated with topical tacrolimus. Clin Exp Dermatol 2003; 28: 456-8.
13. Simon D, Boudny C, Nievergelt H et al. Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol 2004; 150: 1033-5.
14. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001; 44: 995-8.
15. Bamford JT, Elliott BA, Haller IV. Tacrolimus effect on rosacea. J Am Acad Dermatol 2004; 50: 107-8.
16. Brouard MC, Prins C, Chavaz P et al. Erosive pustular dermatosis of the leg: report of three cases. Br J Dermatol 2002; 147: 765-9.
17. Laffitte E, Kaya G, Piguet V, Saurat JH. Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. Arch Dermatol 2003; 139: 712-4.
18. Kawaguchi M, Mitsuhashi Y, Kondo S. Successful treatment of eosinophilic pustular folliculitis with topical tacrolimus. Int J Dermatol 2004; 43: 608-10.
19. Yamamoto S, Jiang H, Kato R. Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol 1994; 102: 160-4.
20. Maurer M, Handjiski B, Paus R. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol 1997; 150: 1433-41.
21. Schuppe HC, Homey B, Assmann T et al. Topical tacrolimus for pyoderma gangrenosum. Lancet 1998; 351: 832.
22. Lyon CC, Stapleton M, Smith AJ et al. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatol Treat 2001; 12: 13-7.
23. Ludwig E, Allam JP, Bieber T, Novak N. New treatment modalities for granuloma faciale. Br J Dermatol 2003; 149: 634-7.
24. Rao NG, Pariser RJ. Annular erythema responding to tacrolimus ointment. J Drugs Dermatol 2003; 2: 421-4.
25. Bohm M, Frieling U, Luger TA, Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139: 922-4.
26. Mancuso G, Berdondini RM. Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol 2003; 13: 590-2.
27. Harth W, Linse R. Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br J Dermatol 2004; 150: 792-4.
28. Jain S, Stephens CJ. Successful treatment of disseminated granuloma annulare with topical tacrolimus. Br J Dermatol 2004; 150: 1042-3.
29. Ko MJ, Chu CY. Topical tacrolimus therapy for localized bullous pemphigoid. Br J Dermatol 2003; 149: 1079-81.
30. Lebeau S, Mainetti C, Masouye I et al. Localized childhood vulval pemphigoid treated with tacrolimus ointment. Dermatology 2004; 208: 273-5.
31. Hodgson TA, Malik F, Hegarty AM, Porter SR. Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris. Eur J Dermatol 2003; 13: 142-4.
32. Vecchietti G, Kerl K, Hugli A et al. Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. Br J Dermatol 2003; 148: 833-4.
33. Banky JP, Sheridan AT, Storer EL, Marshman G. Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. Arch Dermatol 2004; 140: 794-6.
34. Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch Dermatol 2003; 139: 1401-2.
35. Rabeni EJ, Cunningham NM. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002; 47: 797-8.
36. Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 2002; 147: 154-6.
37. Walker SL, Kirby B, Chalmers RJ. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002; 147: 405-6.
38. Kanekura T, Yoshii N, Terasaki K et al. Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol 2003; 148: 353-6.
39. Bohm M, Gaubitz M, Luger TA et al. Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases. Dermatology 2003; 207: 381-5.
40. Lampropoulos CE, Sangle S, Harrison P et al. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology 2004; 43: 1383-5.
41. Elad S, Or R, Resnick I, Shapira MY. Topical tacrolimus - a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transpl Int 2003; 16: 665-70.
42. Schuppe H, Richter-Hintz D, Stierle HE et al. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis. Rheumatology 2000; 39: 105-6.
43. Hodgson T, Hegarty A, Porter S. Topical tacrolimus and Crohn disease. J Pediatr Gastroenterol Nutr 2001; 33: 633.
44. Yoshimasu T, Ohtani T, Sakamoto T et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002; 12: 50-2.
45. Hollar CB, Jorizzo JL. Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatolog Treat 2004; 15: 35-9.
46. Castanedo-Cazares JP, Lepe V, Moncada B. Lichen amyloidosis improved by 0.1% topical tacrolimus. Dermatology 2002; 205: 420-1.